Steroid receptors in human breast cancer

Robert B Clarke1, Elizabeth Anderson, Anthony Howell

  • 1CR-UK Department of Medical Oncology, Christie Hospital, Manchester, UK. rclarke@picr.man.ac.uk

Insights

Ovarian steroids like estrogen are vital in breast cancer. New receptor discoveries prompt a re-evaluation of their roles and interactions, potentially revealing new therapeutic targets for endocrine resistance.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Ovarian steroids, particularly estrogen, are critical for breast development and cancer growth.
  • Estrogen receptor (ER) signaling is a key target in breast cancer therapy.
  • Tumor dependence on estrogen necessitates understanding ER biology in cancer progression.

Purpose of the Study:

  • To reappraise the roles of estrogen and progesterone receptors in breast development and cancer.
  • To investigate novel genes and protein isoforms of these receptors.
  • To explore interactions between estrogen receptor biology and other signaling pathways.

Main Methods:

  • Review of recent discoveries in nuclear receptor research.
  • Analysis of estrogen receptor biology changes during tumorigenesis.
  • Examination of crosstalk between growth factor pathways and estrogen signaling.

Main Results:

  • Discovery of novel receptor genes and protein isoforms for estrogen and progesterone.
  • Identification of critical changes in estrogen receptor biology during cancer development.
  • Elucidation of complex interactions with growth factor signaling pathways.

Conclusions:

  • New receptor insights necessitate a re-evaluation of ovarian steroid roles in breast cancer.
  • Understanding ER biology shifts is crucial for comprehending tumorigenesis.
  • Interactions with growth factor pathways offer potential targets for overcoming endocrine resistance.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...